BIOFORCE NANOSCIENCES HOLDINGS, INC.
Data quality: 83%
BFNH
OTC
Manufacturing
Measuring & Analyzing Instruments
$0.45
$0.00
(0.00%)
Mkt Cap: 15.08 M
Price
$0.45
Mkt Cap
15.08 M
Day Range
$0.28 — $0.28
52-Week Range
$0.18 — $0.95
Volume
467
Open $0.28
50D / 200D Avg
$0.51
12.52% below
50D / 200D Avg
$0.63
29.00% below
Quick Summary
Key Takeaways
Negative free cash flow of -69,064.0
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio0.00
Interest CoverageN/A
Valuation
PE (TTM)
-11.63
Below sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -11.6 | -1.5 |
| P/B | — | 1.6 |
| ROE % | — | -53.4 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -1.30 M |
| ROE | N/A | ROA | -153523.51% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -69,064.0 |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.00 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | -499,938 | Tangible Book Value | -499,938 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -11.63 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -0.46% | ||
| Market Cap | 15.08 M | Enterprise Value | 15.08 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.05 | Revenue / Share | N/A |
| FCF / Share | 0.00 | OCF / Share | 0.00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 5.33% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | 17,775.0 |
| Net Income | -490,437.0 | -471,953.0 | -485,514.0 | -501,955.0 | -158.41 M |
| EPS (Diluted) | -0.02 | -0.02 | — | — | — |
| Gross Profit | — | — | — | — | 4,360.0 |
| Operating Income | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 862.0 | 638.0 | 734.0 | 11,145.0 | 39,865.0 |
| Total Liabilities | 2.30 M | 1.82 M | 1.35 M | 873,008.0 | 399,773.0 |
| Shareholders' Equity | -2.30 M | -1.82 M | -1.35 M | -861,863.0 | -359,908.0 |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 862.0 | 638.0 | 734.0 | 11,105.0 | 39,865.0 |
| Current Assets | 862.0 | 638.0 | 734.0 | 11,145.0 | 39,865.0 |
| Current Liabilities | 2.30 M | 1.82 M | 1.35 M | 873,008.0 | 399,773.0 |
{"event":"ticker_viewed","properties":{"ticker":"BFNH","listing_kind":"stock","pathname":"/stocks/bfnh","exchange":"OTC","country":"US"}}